The 1, 2, 3-triazole 'all-in-one'ring system in drug discovery: A good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool

D Lengerli, K Ibis, Y Nural… - Expert opinion on drug …, 2022 - Taylor & Francis
ABSTRACT Introduction The 1, 2, 3-triazole ring occupies an important space in medicinal
chemistry due to its unique structural properties, synthetic versatility and pharmacological …

Recent advances of chroman-4-one derivatives: synthetic approaches and bioactivities

S Emami, Z Ghanbarimasir - European Journal of Medicinal Chemistry, 2015 - Elsevier
Chroman-4-one scaffold is a privileged structure in heterocyclic chemistry and drug
discovery. Also, chroman-4-ones are important intermediates and interesting building blocks …

Copper catalysis in living systems and in situ drug synthesis

J Clavadetscher, S Hoffmann, A Lilienkampf… - Angewandte …, 2016 - Wiley Online Library
The copper‐catalyzed azide–alkyne cycloaddition (CuAAC) reaction has proven to be a
pivotal advance in chemical ligation strategies with applications ranging from polymer …

Triazole: a promising antitubercular agent

RS Keri, SA Patil, S Budagumpi… - Chemical biology & …, 2015 - Wiley Online Library
Tuberculosis is a contagious disease with comparatively high mortality worldwide. The
statistics shows that around three million people throughout the world die annually from …

A Metal‐Free Three‐Component Reaction for the Regioselective Synthesis of 1, 4, 5‐Trisubstituted 1, 2, 3‐Triazoles

J Thomas, J John, N Parekh, W Dehaen - Angewandte Chemie, 2014 - Wiley Online Library
A metal‐free three‐component reaction to synthesize 1, 4, 5‐trisubstituted 1, 2, 3‐triazoles
from readily available building blocks, such as aldehydes, nitroalkanes, and organic azides …

Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity

DS Reddy, M Kongot, A Kumar - Tuberculosis, 2021 - Elsevier
Tuberculosis (TB) is a highly contagious airborne disease with nearly 25% of the world's
population infected with it. Challenges such as multi drug resistant TB (MDR-TB), extensive …

Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: A bioinformatics approach

RP Leão, JV Cruz, GV da Costa, JN Cruz… - Pharmaceuticals, 2020 - mdpi.com
The cyclooxygenase-2 receptor is a therapeutic target for planning potential drugs with anti-
inflammatory activity. The selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib was …

Recent developments on triazole nucleus in anticonvulsant compounds: a review

MX Song, XQ Deng - Journal of enzyme inhibition and medicinal …, 2018 - Taylor & Francis
Epilepsy is one of the common diseases seriously threatening life and health of human.
More than 50 million people are suffering from this condition and anticonvulsant agents are …

Pivotal role of nitrogen heterocycles in Alzheimer's disease drug discovery

S Kumari, K Maddeboina, RD Bachu, SHS Boddu… - Drug Discovery …, 2022 - Elsevier
Alzheimer's disease (AD) is a detrimental neurodegenerative disease that progressively
worsens with time. Clinical options are limited and only provide symptomatic relief to AD …

Recent advancements in 1, 4-disubstituted 1H-1, 2, 3-triazoles as potential anticancer agents

K Lal, P Yadav - Anti-Cancer Agents in Medicinal Chemistry …, 2018 - ingentaconnect.com
Cancer is a class of formidable disease with high degree of mortality. Despite much
progress in chemotherapy, the problem of drug resistance has led to the search for newer …